BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 17, 2007
View Archived Issues
Promising preclinical activity of new plant-produced vaccine candidates at Integrated
Read More
Anti-Abeta fusion antibody successfully delivered to the brain through a molecular Trojan horse
Read More
Recent patents impart new therapeutic agents for cancer
Read More
Recent patents disclose new therapeutic agents for anxiety, depression and sleep disorders
Read More
Snapshots: Preclinical studies of agents under development for schizophrenia
Read More
Snapshots of studies of isavuconazole activity
Read More
Senetek initiates clinical trials of Pyratine 6 for acne rosacea
Read More
Alpha-lipoic acid studied for prevention of chemotherapy-induced neuropathy
Read More
HuMax-EGFr studied with chemoradiation for NSCLC
Read More
New phase II trial studies EndoTAG-1 for triple receptor negative breast cancer
Read More
MEK inhibitor ARRY-704 begins phase I trial in cancer patients
Read More
Positive topline phase II results for DX-88 in hereditary angioedema
Read More
Hadasit and Yissum jointly disclose novel antifungal agents in recent patent
Read More
Cardiac myosin activator CK-1827452 begins phase II development
Read More
Promacta studied in patients previously treated for chronic ITP
Read More
Merck licenses Coley's VaxImmune vaccine adjuvant
Read More
Japanese budget clearance for studies of H5N1 flu vaccine and Ampligen
Read More
Poniard begins phase I trial of oral picoplatin
Read More
Enrollment open in phase II study of A-002 for stable coronary artery disease
Read More
GSK presents new pan-Akt inhibitor at AACR meeting
Read More
PI-88 improves disease-free survival in liver cancer patients after surgery
Read More
ECE-1 as a novel target in breast cancer therapy
Read More
FDA Advisory Committee votes against recommending approval of Arcoxia
Read More
QBI-139, an EVade(TM) ribonuclease variant, proves safe in rodents
Read More
LB-80317 shows broad spectrum anti-HBV activity against resistant mutants in vitro
Read More
Phase I results reported at AACR meeting for brain-penetrating doxorubicin analogue
Read More
Good safety and pharmacokinetic profile for multiple-dose PTC-299 in humans
Read More